Alewine C - Search Results

1

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.

Skorupan N, Peer CJ, Zhang X, Choo-Wosoba H, Ahmad MI, Lee MJ, Rastogi S, Sato N, Yu Y, Pegna GJ, Steinberg SM, Kalsi SS, Cao L, Figg WD, Trepel JB, Pastan I, FitzGerald D, Alewine C. Skorupan N, et al. Among authors: alewine c. Front Oncol. 2024 Apr 19;14:1386190. doi: 10.3389/fonc.2024.1386190. eCollection 2024. Front Oncol. 2024. PMID: 38706610 Free PMC article.

2

Lin-7 targets the Kir 2.3 channel on the basolateral membrane via a L27 domain interaction with CASK.

Alewine C, Kim BY, Hegde V, Welling PA. Alewine C, et al. Am J Physiol Cell Physiol. 2007 Dec;293(6):C1733-41. doi: 10.1152/ajpcell.00323.2007. Epub 2007 Oct 3. Am J Physiol Cell Physiol. 2007. PMID: 17913842 Free article.

3

TIP-1 has PDZ scaffold antagonist activity.

Alewine C, Olsen O, Wade JB, Welling PA. Alewine C, et al. Mol Biol Cell. 2006 Oct;17(10):4200-11. doi: 10.1091/mbc.e06-02-0129. Epub 2006 Jul 19. Mol Biol Cell. 2006. PMID: 16855024 Free PMC article.

4

Megakaryocytic potentiating factor and mature mesothelin stimulate the growth of a lung cancer cell line in the peritoneal cavity of mice.

Zhang J, Bera TK, Liu W, Du X, Alewine C, Hassan R, Pastan I. Zhang J, et al. Among authors: alewine c. PLoS One. 2014 Aug 13;9(8):e104388. doi: 10.1371/journal.pone.0104388. eCollection 2014. PLoS One. 2014. PMID: 25118887 Free PMC article.

5

Efficacy of RG7787, a next-generation mesothelin-targeted immunotoxin, against triple-negative breast and gastric cancers.

Alewine C, Xiang L, Yamori T, Niederfellner G, Bosslet K, Pastan I. Alewine C, et al. Mol Cancer Ther. 2014 Nov;13(11):2653-61. doi: 10.1158/1535-7163.MCT-14-0132. Epub 2014 Sep 19. Mol Cancer Ther. 2014. PMID: 25239937 Free PMC article.

6

Advances in anticancer immunotoxin therapy.

Alewine C, Hassan R, Pastan I. Alewine C, et al. Oncologist. 2015 Feb;20(2):176-85. doi: 10.1634/theoncologist.2014-0358. Epub 2015 Jan 5. Oncologist. 2015. PMID: 25561510 Free PMC article. Review.

7

High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.

Thomas A, Chen Y, Steinberg SM, Luo J, Pack S, Raffeld M, Abdullaev Z, Alewine C, Rajan A, Giaccone G, Pastan I, Miettinen M, Hassan R. Thomas A, et al. Among authors: alewine c. Oncotarget. 2015 May 10;6(13):11694-703. doi: 10.18632/oncotarget.3429. Oncotarget. 2015. PMID: 26028668 Free PMC article. Clinical Trial.

8

New Life for Immunotoxin Cancer Therapy.

Hassan R, Alewine C, Pastan I. Hassan R, et al. Among authors: alewine c. Clin Cancer Res. 2016 Mar 1;22(5):1055-8. doi: 10.1158/1078-0432.CCR-15-1623. Epub 2015 Oct 13. Clin Cancer Res. 2016. PMID: 26463707 Free PMC article.

9

Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses.

Strauss J, Alewine C, Figg WD, Duffy A. Strauss J, et al. Among authors: alewine c. Clin Transl Oncol. 2016 Jul;18(7):653-9. doi: 10.1007/s12094-015-1459-8. Epub 2015 Dec 11. Clin Transl Oncol. 2016. PMID: 26661112 Free PMC article. Review.

10

Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy.

Illei PB, Alewine C, Zahurak M, Cowan ML, Montgomery E, Hassan R, Xiang L, Pastan I, Kelly RJ. Illei PB, et al. Among authors: alewine c. Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):246-52. doi: 10.1097/PAI.0000000000000292. Appl Immunohistochem Mol Morphol. 2016. PMID: 26894650 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters